Plus, Gap’s Athleta brand is launching a workout and wellness platform, Tesla is reportedly moving its showrooms out of malls, and ride sharing app Swvl is going public via a reverse merger with a SPAC.
Read MorePlus, the S&P 500 is hovering near its record ahead of a busy earnings week with some of tech’s biggest names reporting, Bitcoin surged to nearly $39,000 on speculation that Amazon may soon accept cryptocurrencies as payment, and BioNTech said it plans to develop an mRNA vaccine for malaria.
Read MorePlus, Twitter also delivered a beat, Boston Beer cited disappointing demand for its hard seltzer as cause for its earnings results miss, and Alphabet launched a new robotics software startup.
Read MoreBioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial […]
Read MorePlus, Canada said it will allow cruise ships to operate in its waters beginning on November 1, Moderna is joining the S&P 500 next week, and Lordstown Motors confirmed it is being investigated by the Justice Department.
Read MorePlus, Morgan Stanley delivered an earnings beat, Taiwan Semiconductor said it expects sales to rise more than 20% in 2021, and Netflix is pushing into video games with its latest executive hire.
Read MorePlus, Apple asked suppliers to increase iPhone production by 20%, Citigroup delivered an earnings beat, and a short seller accused Oatly of misleading investors and consumers.
Read MorePlus, Pfizer said it is meeting with U.S. health officials today to discuss its COVID-19 vaccine booster shot, Walmart’s Flipkart just completed a $3.6 billion funding round, and grill maker Weber has filed to go public.
Read MoreBuy Price: $235.00 or better Sell Signal: TradersPro Sell Signal Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 […]
Read MorePlus, Wells Fargo said it is shutting down all personal lines of credit to focus more on its credit card and personal loans business, Pfizer plans to apply for emergency use authorization for a booster shot of its COVID-19 vaccine in August, and Stamps.com has agreed to be taken private by Thoma Bravo.
Read MorePlus, jobless claims were higher than expected last week, three dozen state attorneys general filed a new antitrust suit against Google, and Beyond Meat has debuted its new faux-chicken tenders.
Read More